The primary purpose of this study is to explore the association of high sensitivity C-reactive protein (hsCRP) and radiotherapy(RT)-induced toxicity in patients with nasopharyngeal carcinoma. In each patient, hsCRP levels in the pre- and post-RT plasma samples will be measured according to the schedule we set.
Study Type
OBSERVATIONAL
Enrollment
300
Only clinical parameters were recorded, no intervention was made.
hsCRP levels
The hscrp levels in the plasma samples from each participant were measured at the following time points: 1. at the time of diagnosis completion/before the initiation of the first neoadjuvant chemotherapy 2. before the initiation of each neoadjuvant chemotherapy 3. before the initiation of the first radiotherapy 4. during radiotherapy, once a week 5. 1 week and 4weeks after the last radiotherapy
Time frame: Through treatments completion，12 weeks
Incidence of adverse events
All adverse events were recorded during treatment(for example, oral mucositis, dermatitis).
Time frame: Through treatments completion，12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.